INTERNATIONAL PATENT: HANMI PHARM. CO. LTD., 한미약품 주식회사 FILES APPLICATION FOR "USE OF CRF2 RECEPTOR AGONIST AND ACYLATED CONJUGATE THEREOF"

GENEVA, Nov. 11 -- HANMI PHARM. CO. LTD. (214 Muha-ro, Paltan-myeon, Hwaseong-siGyeonggi-doGyeonggi-do 18536), 한미약품 주식회사 (경기도화성시팔탄면 무하로 214) filed a patent application (PCT/KR2025/005692) for "USE OF CRF2 RECEPTOR AGONIST AND ACYLATED CONJUGATE THEREOF" on Apr 28, 2025. With publication no. WO/2025/230248, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KIM, Eun Seon (214 Muha-ro, Pal...